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Abstract 
Most high-income ŶĂƚŝŽŶƐŝƐƐƵĞŐƵŝĚĞůŝŶĞƐŽŶůŽǁƌŝƐŬĚƌŝŶŬŝŶŐƚŽŝŶĨŽƌŵŝŶĚŝǀŝĚƵĂůƐ ?ĚĞĐŝƐŝŽŶƐĂďŽƵƚ
alcohol consumption.  However, leading scientists have criticised the processes for setting the 
consumption thresholds within these guidelines for a lack of objectivity and transparency.  This 
paper examines how guideline developers should respond to such criticisms and focuses particularly 
on the balance between epidemiological evidence, expert judgement and pragmatic considerations.  
Although primarily concerned with alcohol, our discussion is also relevant to those developing 
guidelines for other health-related behaviours.  We make eight recommendations across three 
areas.  First, recommendations on the use of epidemiological evidence: (1) Guideline developers 
should assess whether the available epidemiological evidence is most appropriately communicated 
as population-level messages (e.g. suggesting reduced drinking benefits populations rather than 
individuals); (2) Research funders should prioritise commissioning studies on the acceptability of 
different alcohol-related risks (e.g. mortality, morbidity, harms to others) to the public and other 
stakeholders; (3) Guideline developers should request and consider statistical analyses of 
epidemiological uncertainty.  Second, recommendations to improve objectivity and transparency 
when translating epidemiological evidence into guidelines: (4) Guideline developers should specify 
and publish their analytical framework to promote clear, consistent and coherent judgements; (5) 
'ƵŝĚĞůŝŶĞĚĞǀĞůŽƉĞƌƐ ?ĚĞĐŝƐŝŽŶ-making should be supported by numerical and visual techniques 
which also increase the transparency of judgements to stakeholders. Third, recommendations 
relating to the diverse use of guidelines: (6) Guideline developers and their commissioners should 
give meaningful attention to how guidelines are used in settings such as advocacy, health 
promotion, clinical practice and wider health debates, as well as in risk communication; (7) Guideline 
developers should make evidence-based judgements that balance epidemiological and pragmatic 
concerns to maximise the communicability, credibility and general effectiveness of guidelines; (8) As 
with scientific judgements, pragmatic judgements should be reported transparently. 
 
  
Summary statement: Leading scientists have criticised the objectivity and transparency of processes 
used when setting consumption thresholds for low risk drinking guidelines.  Improving 
epidemiological analysis techniques, the deployment of expert judgement, the incorporation of 
pragmatic concerns and the balance between these can help to address this problem.  
Introduction 
Most high-income countries issue guidelines on low risk drinking to inform ŝŶĚŝǀŝĚƵĂůƐ ?ĚĞcisions 
about alcohol consumption [1, 2].  &ŽƌĞǆĂŵƉůĞ ?ƚŚĞh<ŚŝĞĨDĞĚŝĐĂůKĨĨŝĐĞƌƐ ?ŐƵŝĚĞůŝŶĞƐƚĂƚĞƐƚŚĂƚ
 “dŽŬĞĞƉŚĞĂůƚŚƌŝƐŬƐĨƌŽŵĂůĐŽŚŽůƚŽĂůŽǁůĞǀĞů ?ŝƚŝƐƐĂĨĞƐƚŶŽƚƚŽĚƌŝŶŬŵŽƌĞƚŚĂŶ ? ? units a week 
ŽŶĂƌĞŐƵůĂƌďĂƐŝƐ ?/ĨǇŽƵƌĞŐƵůĂƌůǇĚƌŝŶŬĂƐŵƵĐŚĂƐ ? ?ƵŶŝƚƐƉĞƌǁĞĞŬ ?ŝƚ ?ƐďĞƐƚƚŽƐƉƌĞĂĚǇŽƵƌ
ĚƌŝŶŬŝŶŐĞǀĞŶůǇŽǀĞƌƚŚƌĞĞŽƌŵŽƌĞĚĂǇƐ ?[3].  An expert committee usually recommends these 
guidelines after a review of epidemiological evidence; however, there are no standardised methods 
for committees to follow.  This is particularly true when setting the consumption threshold (i.e. the 
14 units a week in the above example), which is usually the most visible and contested element of 
the guidelines [1, 4].  Therefore, this paper aims to examine and make recommendations on the 
epidemiological and practical challenges faced by guideline developers when setting such 
thresholds.   
The paper comprises five sections.  The first describes contemporary drinking guidelines and their 
development, giving particular attention to the recent use of epidemiological modelling to inform 
selection of the consumption thresholds [5, 6].  The second section critically examines such 
modelling and identifies conceptual and methodological priorities for research and practice.  The 
third section move away from epidemiology to assess how guideline developers should deploy 
expert judgement and make this transparent when translating evidence into practice and, in the 
fourth section, considers how guideline developers should respond to the practical challenges arising 
ĨƌŽŵƐŽĐŝĞƚǇ ?ƐĚŝǀĞrse uses of drinking guidelines.  The final section summarises our 
recommendations, discusses the tensions between evidence, judgement and pragmatism, and 
presents our concluding comments.  Throughout the paper, we draw on our experience of providing 
epidemiological modelling to the 2016 UK Guideline Development Group and our understanding of 
other guideline development processes as reported by those involved.  While drinking guidelines 
often discuss a diverse set of behaviours, populations and practices (e.g. binge drinking, youth 
drinking, drinking in the workplace), we focus on the setting of thresholds for daily or weekly alcohol 
consumption as they are the principal focus of scientific and public debate.   
Contemporary drinking guidelines and their development 
Drinking guidelines have proliferated internationally since the 1980s [1]; however, the drinkers and 
types of drinking targeted and the consumption thresholds set differ between countries and over 
time [2, 7, 8]. This geographic and temporal diversity may be a positive reflection of demographic 
variation, concern about alcohol-related harm rates, improved epidemiological evidence and distinct 
drinking cultures.  Similarly, it may capture different definitions of a standard drink or intended 
purposes for guidelines (e.g. Danish guidelines switched focus from a consumption threshold that 
avoided high risks to one that ensured low risks in 2010) [1].  However, international diversity may 
also signal practical problems.  Leading scientists with experience of developing guidelines have 
argued that the development processes lack objective methods and transparent documentation [4, 
9, 10].  They suggest that guideline developers ŽĨƚĞŶ “ƐĞĞŵƚŽŚĂǀĞĚƌĂǁŶĂĚĞĞƉĐŽůůĞĐƚŝǀĞďƌĞĂƚŚ
and simply voted for specific cut-ŽĨĨůĞǀĞůƐ ?[4: 137], that thresholds for single occasion drinking in 
ƉĂƌƚŝĐƵůĂƌĂƌĞ “ĂŵĂƚƚĞƌŽĨŽƉĂƋƵĞĐŽůůĞĐƚŝǀĞĞǆƉĞƌƚŽƉŝŶŝŽŶ ?[4: 137] and that decision-making has 
 “ĂŶĞůĞŵĞŶƚŽĨŵǇƐƚĞƌǇ ?ĂŶĚŝƐ “ĂƌďŝƚƌĂƌŝůǇůŝŵŝƚĞĚƚŽŚĞĂůƚŚƌŝƐŬ ?[9].  Taken together, these 
accounts suggest there is something unsatisfactory about the way consumption thresholds are set.  
This problem is not unique to alcohol [11-13], but it is important as drinking guidelines are often key 
components of national alcohol policies and attract controversy that can be fuelled by apparent 
subjectivity and opacity [14, 15].   
In this context, we welcome recent efforts to subject the setting of consumption thresholds to 
scientific scrutiny [1, 16, 17].  In particular, guideline development processes in Australia in 2009, 
Canada in 2011 and the UK in 2016 adopted novel methods that enhanced objectivity and 
transparency when setting their thresholds [5, 18, 19].  In each case, guideline developers compared 
one of two a priori ĚĞĨŝŶŝƚŝŽŶƐŽĨ ‘ůŽǁƌŝƐŬ ? against a synthesis of epidemiological evidence to inform 
selection of the final threshold.  We refer to these low risk definitions as the Canadian and Australian 
approaches.  The Canadian approach focuses on relative risks and defines low risk drinking as the 
consumption level where the all-cause mortality risk is equal to that of abstainers (Figure 1a) [20].  In 
contrast, the Australian approach focuses on absolute risks and attempts to identify the level of 
alcohol-ƌĞůĂƚĞĚƌŝƐŬƚŚĂƚŝƐ ‘ĂĐĐĞƉƚĂďůĞ ?ƚŽƚŚĞƉƵďůŝĐ.  After a review of risk governance literature and 
evidence from other behaviours, this acceptability threshold is set at the consumption level 
corresponding to a 1% lifetime risk of alcohol-attributable death [4, 19] (Figure 1b).  The Australian 
approach has proved particularly influential, informing the 2010 Danish, 2016 UK and 2017 French 
guidelines, as well as the pan-European Reducing Alcohol Related Harm (RARHA) project, which used 
the 1% threshold to suggest guideline consumption thresholds for seven European countries [1, 21-
23].  
[Figures 1a and 1b about here] 
Developing the use of epidemiological evidence when setting consumption thresholds 
The relative merits of the Canadian and Australian approaches (hereafter the exemplar approaches) 
are debated elsewhere [4, 9, 17, 20, 24], but the epidemiological modelling that underpins them 
requires critical examination.  It has considerable strengths including tailoring the models to local 
populations by synthesising international evidence on alcohol-related health risks with national data 
on alcohol consumption and health outcomes [5, 9].  This means the resulting evidence provides 
nationally-specific estimates of alcohol-related health risks.  It can also indicate the appropriateness 
of alternative consumption thresholds, aid comparison of risks across population subgroups and 
inform judgements on how new evidence might change previous decisions.  However, there are 
important limitations and we use three key questions below to illustrate these, consider their 
implications and make recommendations for further research.  
Question 1: A low risk for whom? 
The rationale for the exemplar approaches implies a given individual drinking at the consumption 
threshold faces a specified lifetime alcohol-attributable mortality risk.  For example, the UK 
guidelines suggest an individual drinking 14 units per week will accumulate across their lifetime an 
approximately 1% risk of dying due to alcohol [25: 3].  However, such claims are typically derived 
from an estimate of the average risk for the population (or for males and females separately).  This 
assumes implicitly that the population ?Ɛ average risk is equal to each ŝŶĚŝǀŝĚƵĂů ?Ɛ risk.  Although 
commonplace, this assumption is problematic for at least three reasons.  First, the population ?Ɛ 
average risk aggregates many individual-level risks that vary substantially by age, socioeconomic 
status, genetic profile, wider health-related behaviours and experiences of inequalities [23, 26, 27].  
For example, drinkers of lower socioeconomic status incur greater risks than counterparts of higher 
socioeconomic status for each unit of alcohol consumed [26].  Second, differences in the average 
risks associated with lighter and heavier drinking populations do not necessarily equate to changes 
in risk for individuals who move between these consumption groups, in part because previous 
drinking will continue to influence each ŝŶĚŝǀŝĚƵĂů ?Ɛ health outcomes [28].  Third, the population-
average risk is a synthesis of risks for diverse health outcomes (e.g. heart disease, cancer, injuries) 
which have differently shaped risk relationships with alcohol consumption and are more or less 
relevant to different sociodemographic groups [29] ?dŚŝƐŵĞĂŶƐƚŚĂƚĂŶŝŶĚŝǀŝĚƵĂů ?ƐĐŚĂƌĂĐƚĞƌŝƐƚŝĐƐ
will not only determine the level of risk they face, but also the type of risk and how that risk changes 
in line with their alcohol consumption.  For these reasons, the exemplar approaches may provide a 
population-level rationale for setting the consumption threshold at a particular level, but they do not 
provide a robust explanation for why that threshold is appropriate for any given individual.  
We suggest guideline developers might consider two responses to this problem.  First, health 
authorities may wish to produce more personalised guidance on alcohol consumption, akin to the 
cardiovascular QRISK score (which excludes alcohol use) [30] or equivalents within popular health 
monitoring technologies [31].  We do not favour this response at this stage in the development of 
the evidence base because the capacity of epidemiology to identify who will benefit from 
behavioural change is disputed [32, 33], the associated evidence is inherently imprecise (see below) 
and a meta-analysis of studies evaluating the effectiveness of communicating personalised genetic 
risks did not change behaviour or behavioural motivations [34].  Ethical challenges may also arise 
including the risk of blaming individuals who are subject to structural risks factors for their failure to 
achieve good health [35-37] and the need to decide whether increased alcohol-related health risks 
for those in lower socioeconomic groups mean the poor should be advised to drink less than the 
wealthy [26, 27].   
A second response is to design population-level risk messages.  Rather than suggesting that 
individuals who drink at the consumption threshold face a 1% lifetime risk of dying due to alcohol, a 
population message might read,  ‘If everyone drinks within the guideline consumption level, no more 
than 1 in 100 will die due to alcohol. ?  The use and effectiveness of population-level messages is 
under-researched and they require evaluation to assess whether they have sufficient personal 
salience to affect behaviour.  Nonetheless, they do describe the evidence provided by the exemplar 
approaches more accurately than individualised counterparts and, in line with the prevention 
paradox [38], they avoid implying that any given individual will benefit meaningfully from small 
reductions in risk.  
Question 2: How much risk is acceptable? 
Consideration of risk acceptability within the Australian approach usefully moves beyond 
epidemiology and addresses peoplĞ ?Ɛinteractions with risk.  However, the acceptability threshold 
has limited evidential support as no study has examined the specific acceptability of alcohol-related 
risks.  Instead, alcohol researchers have drawn heavily on a 1969 analysis by Starr.  Starr used data 
on fatalities from selected activities, alongside the time and money spent on them, to conclude that 
the public will accept voluntary risks from behaviours such as drinking that are 1,000 times greater 
than involuntary risks, for which acceptability standards can be found in environmental hazard 
regulations [39, 40].  zĞƚ ?^ƚĂƌƌ ?ƐǁŽƌŬŚĂƐĂŶƵŵďĞƌŽĨůŝŵŝƚĂƚŝŽŶƐ ?dŚĞĂƵƚŚŽƌǀŝĞǁĞĚhis empirical 
analysis as  ‘ĞǆƉůŽƌĂƚŽƌǇ ?ĂŶĚhis conceptualisation of risk as incomplete [39, 41].  Others have since 
identified dimensions beyond voluntariness that influence risk acceptability, including ƚŚĞƌŝƐŬ ?Ɛ
potential to cause immediate, catastrophic or severe harm, whether it evokes feelings of dread, its 
perceived controllability or newness, and associated public or scientific knowledge [42].  Also 
problematic is ^ƚĂƌƌ ?Ɛreliance on revealed preferences (i.e. observed behaviours), which equate risk-
taking to risk acceptance, assume that observed behaviours do not result from unobserved 
constraints (e.g. family or work commitments) and presume that the observer values risks and 
benefits similarly to the observed [41].  Further limitations of the Australian approach to assessing 
the acceptability of alcohol-related risks include focusing only on mortality as an outcome, rather 
than on morbidity, dependence, negative experiences or harming others [43], and a failure to weigh 
the risks of drinking against its benefits, particularly when comparing the acceptability of alcohol-
related risks to those associated with other behaviours  
Given these limitations, research priorities to improve understanding of alcohol-related risk 
acceptability include using surveys to identify how the acceptability of different alcohol-related 
outcomes varies on the above dimensions of risk acceptability, using discrete choice experiments to 
identify risk acceptability thresholds for alcohol-related outcomes and assessing how these are 
affected by knowledge of the consumption levels and patterns associated with those thresholds, and 
using qualitative methods to understand how risk acceptability informs drinking practices.  Where 
feasible, each of the above should attend to variation in risk acceptability across key population 
subgroups.  
Question 3: How certain can we be? 
The limitations of alcohol epidemiology mean that risk estimates involve a significant degree of 
imprecision and the exemplar approaches do not engage with this.  Example limitations include the 
substantial underestimation of alcohol consumption within epidemiological surveys, which leads to 
overestimation of risks for a given level of alcohol consumption [44], and commonplace biases in 
observational studies (e.g. in sample selection, definition of abstainers and controls for confounding) 
which are widely discussed in relation to the putative cardioprotective effects of moderate drinking, 
but apply also to many other health conditions to an unknown degree and in potentially differing 
directions [45, 46].  Other uncertainties arise from weak measurement of lifetime drinking 
trajectories, patterns and practices [28, 47, 48] and necessary assumptions embedded within 
epidemiological models (e.g. regarding the relationships between alcohol consumption and risks of 
injuries[5]).  In practice, these uncertainties mean the consumption level corresponding to a given 
definition of  ‘low risk ? may be identifiable only as a range of plausible values.   
Guideline developers should request sensitivity analyses using alternative valid assumptions about 
the epidemiological evidence to quantify the extent of uncertainty.  Figure 2 summarises selected 
results from the sensitivity analyses that we provided to the UK Guideline Development Group [5].  It 
shows that the consumption threshold implied by the Australian approach for men varies between 
21g and 159g per week depending on the assumptions made.  The Group also considered further 
unquantified uncertainty relating to underestimation of alcohol consumption.  We envisage that 
future guideline developers will face similarly imprecise evidence as, despite methodological 
advances [e.g. 44, 47, 49, 50-53], many of the above limitations are inherent to epidemiology [5, 54, 
55].   
[Figure 2 about here] 
The three discussions above demonstrate that while the exemplar approaches advance methods for 
setting consumption thresholds, they can only take us so far.  An imperfect evidence base means 
that conceptually clear-cut methods still only lead to a range of broadly appropriate values from 
which guideline developers can select their preferred consumption threshold.  Although the 
supporting evidence is more robust, that range is, arguably, not markedly different to those 
considered under previous, simpler methods.  Two RAHRA reports reflect this gap between theory 
and practice.  The first stresses,  “The chosen methodology does not assume any expert judgements, 
once the acceptable risk thresholds are set. [The guideline] ŝƐďĂƐĞĚƐŽůĞůǇŽŶĞǀŝĚĞŶĐĞ ?[6: 15].  The 
second concedes,  “Such summarising of quantitative data does not replace expert judgement but 
ƉƌŽǀŝĚĞƐĂƚƌĂŶƐƉĂƌĞŶƚĂƉƉƌŽĂĐŚĨŽƌũƵƐƚŝĨǇŝŶŐĞǆƉĞƌƚƐ ?ĐŚŽŝĐĞƐ ?[1: 7].  In the remainder of this 
paper, we discuss how to make the expert judgements necessary to select a consumption threshold 
from the range of appropriate values and how to make those judgements transparent.    
Improving the objectivity and transparency of judgements on epidemiological evidence 
Criticisms of the way guideline consumption thresholds are set do not target the necessary presence 
of expert judgements per se, but focus instead on the subjectivity and opacity of those judgements 
[4].  Subjectivity and opacity can manifest in several ways.  For example, a lack of clarity, consistency 
or coherence may emerge when making multiple judgements in an unstructured manner over a 
lengthy process or report.  This can mean important decisions are unexplained, comparisons are 
distorted by switching between relative and absolute risk metrics, priority is given to condition-
specific risks rather than overall risks, and uncertainties are glossed over inappropriately or given 
undue prominence [6, 56, 57].  Below, we draw on previous guidance to recommend two linked 
ways of improving the execution and communication of expert judgement [12, 58, 59].   
First, we recommend that guideline developers publish and consult upon an explicit analytical 
framework that details the questions, evidence, metrics, procedures and considerations in play 
across all of their judgements.  This should occur at the start of the process and the final framework 
should record and explain any revisions.  Developing an internationally-standardised framework 
would be a useful future exercise but, at present, we suggest including the following: the questions 
to be answered, the types and quality of evidence to be used, the outcomes of interest (e.g. 
mortality, QALYs, harms to others, inequalities), any new analyses to be undertaken and the planned 
approach to uncertainty (e.g. extrapolation, sensitivity analyses).  With regard to the handling of 
epidemiological evidence, the framework might specify whether the focus is on overall- or condition-
specific risks, how to conceptualise the relationship between population- and individual-level risks 
and which risk metrics to use. [57].   
Second, we recommend that guideline developers use systematic and transparent methods to reach 
consensus on each judgement.  Detailed guidance on consensus methods is available elsewhere [60-
65] and we limit our discussion to highlighting numerical and visual approaches, noting that these 
are not mutually exclusive.  Numerical approaches offer excellent transparency by assigning scores 
to alternative decision options, as in some forms of multi-criteria decision analysis [65].  For 
example, where sensitivity analyses point to a range of possible consumption thresholds, developers 
can score each analysis on metrics such as the extent to which it changes their prior position and the 
plausibility of any assumptions made.  They can then use these scores to calculate a weighted 
average score for each of the candidate thresholds.  An alternative numerical approach, as described 
by Dawson et al., is to assess candidate consumption thresholds for their specificity and sensitivity 
when predicting harmful alcohol-related outcomes [16].   
Visual approaches can communicate accessibly and rapidly the nature, coherence and consistency of 
the key judgements made.  We have developed a visualisation in Figure 3 that demonstrates this.  It 
draws on questions that arose when setting the UK consumption threshold, although it is necessarily 
hypothetical as we were not involved in the final decision-making.  The boxes in Figure 3 describe 
key evidence and considerations, the x-axis shows the extent to which each consideration suggested 
a higher or lower threshold than was ultimately selected and the y-axis shows the weight given to 
each consideration by developers when setting the threshold.  &ŽƌĞǆĂŵƉůĞ ?ƚŚĞďŽǆůĂďĞůůĞĚ ‘^ ? ?
EŽƉƌŽƚĞĐƚŝǀĞĞĨĨĞĐƚƐ ?ŝƐƉŽƐŝƚŝŽŶĞĚƚŽŝŶĚŝĐĂƚĞƚŚĂƚsensitivity analyses two suggested the 
appropriate threshold would be much lower if there were no cardioprotective effects and that this 
evidence played a substantial role in the final decision (i.e. the chosen threshold would have been 
much lower if other judgements had not pulled in the opposite direction).  In contrast, the 
underestimation of alcohol consumption within epidemiological surveys points towards a higher 
threshold but this was not given much weight in reaching the final decision (i.e. the threshold would 
be in much the same place even if this was the only consideration).  The value of the diagram is that 
it makes visible to the public the key judgements made by guideline developers and the potential 
and actual impact of those judgements on the final threshold.  If developers exclude considerations, 
prioritise them in decision-making or find that they have little influence on overall risk estimates, 
then this is immediately apparent.  The diagram can be supported in a layered way with brief 
explanations and more detailed commentary within supporting documentation.  
[Figure 3 about here] 
Figure 3 is deliberately unbalanced and suggests an incoherent decision-making process.  This is 
because it omits considerations beyond epidemiological evidence, such as the acceptability, 
credibility and public interpretation of guidelines.  The final section of this paper focuses on these 
pragmatic concerns (and Figure S1 in the appendix presents a balanced version of the diagram that 
incorporates them). 
Making pragmatic considerations meaningful and visible 
Scientific debate on guideline consumption thresholds focuses primarily on epidemiological matters.  
This aligns with the view that drinking guidelines exist to communicate alcohol-related health risks to 
the public.  Yet, guidelines serve a much wider range of purposes.  Practitioners embed them in in 
behaviour change interventions, health promotion campaigns and clinical practice.  Advocates 
leverage the consumption thresholds in public debate to illustrate levels of excess alcohol 
consumption and the need for intervention.  Policy analysts use the same thresholds as benchmarks 
for measuring intervention success or when categorising populations.  The public and commentators 
also discuss and satirise guidelines.  All of this also means that drinking guidelines inevitably 
contribute to definitions and understandings of normative concepts such as responsible, 
irresponsible and binge drinking.  As such, they are not neutral expressions of epidemiological data.  
They are social objects with a history, a literal and symbolic meaning, and a position within political, 
scientific and public practices.   
It is unclear whether and how guideline developers reflect these realities within their decision-
making.  Do consumption thresholds need to be credible with the public and other stakeholders?   
Should public preconceptions, such as those about the excess risk from alcohol faced by women, 
feature in decision-making?  How can consumption thresholds communicate epidemiological 
uncertainty?  Is it better to maintain the status quo to avoid guidelines becoming mired in criticism 
from stakeholders?  These questions mainly put guideline developers in a defensive position, 
adjusting their decisions to limit the adverse consequences for themselves or the public of an 
epidemiologically-driven process.  However, a recent study of the development, communication and 
interpretation of Danish dietary guidance suggests that pragmatic decision-making can form part of 
a positive and strategic approach to health promotion [66].  The Danish guidance recommended 
ĞĂƚŝŶŐƐŝǆƉŽƌƚŝŽŶƐŽĨĨƌƵŝƚĂŶĚǀĞŐĞƚĂďůĞƐĂĚĂǇďƵƚƚŚĞŶƵŵďĞƌ ‘Ɛŝǆ ?ǁĂƐnot based solely on 
epidemiology. Among other considerations was ƚŚĞĐůŽƐĞŶĞƐƐďĞƚǁĞĞŶƚŚĞĂŶŝƐŚǁŽƌĚƐĨŽƌ ‘Ɛŝǆ ?
anĚ ‘ƐĞǆ ?.  This subsequently featured in a highly successful campaign that prioritised pictures of 
amorous vegetables over communicating epidemiology.  Interviews with the public revealed that, 
while the number six gave the guideline legitimacy and communicated a need for dietary discipline 
and self-monitoring, they rarely treated as a literal or important target.  Instead, people drew on lay 
health knowledge, interpreted the guideline in the context of their pre-existing health practices and 
responded in diverse, but often positive, ways.  The lesson is that best practice in setting guideline 
consumption thresholds does not equate solely to robust epidemiological analysis and judgement.  
Instead, it involves meaningful consideration by guideline developers, from the outset, of the 
different ways in which end-users including the public, health professionals, advocates and industry 
will communicate, interpret and put into the practice the guidelines.   
To date, there is little research to support such considerations.  Surveys suggest that few drinkers 
use guidelines to monitor their consumption [67, 68] and qualitative studies report that people 
typically disregard consumption thresholds as they are difficult to accommodate within existing 
drinking practices, rely on an understanding of units that many drinkers do not have, and align 
poorly with more common, embodied ways of monitoring consumption [69-71].  Therefore, 
priorities include further assessment of the credibility and acceptability of guidelines to the public 
and other stakeholders, exploring how the public accommodate guidelines into their existing health 
practices and lay understandings of alcohol-related risks and benefits, and examining how guidelines 
are used by different stakeholders within communications and interventions. 
Recommendations  
The above discussion considers the role of evidence, expert judgement and pragmatism in 
developing consumption thresholds for use within drinking guidelines.  We argue that while 
epidemiological evidence should be central to selecting these thresholds, expert judgements remain 
essential and both must be balanced, deliberately and transparently, against pragmatic 
considerations.  Table 1 summarises our recommendations for achieving that balance.   
[Table 1 about here] 
tĞƌĞĐŽŐŶŝƐĞƚŚĂƚŽƵƌƌĞĐŽŵŵĞŶĚĂƚŝŽŶƐŝŶǀŝƚĞĐƌŝƚŝĐŝƐŵƐƚŚĂƚ ‘ƚŚĞƐĐŝĞŶĐĞ ?ƐŚŽƵůĚďĞƉĂƌĂŵŽƵŶƚ
when developing drinking guidelines.  In our view, arguments for epidemiological purity are 
unconvincing as presenting a single consumption threshold containing a single number is itself a 
necessarily pragmatic response to the need to communicate complex and imprecise evidence in a 
simple and digestible form.  More generally, suggestions that policy must reflect science beyond all 
else are flawed and give insufficient weight to the importance of democratic politics, moral hazard 
and scientific fallibility [72].  Without rejecting ƐĐŝĞŶĐĞ ?Ɛ valuable contribution, we suggest that 
incorporating pragmatic decisions may produce guidelines that are more effective and, indeed, this 
may already be occurring to some degree, for example, when guideline developers elect not to 
communicate uncertainty.  In our view, the pressing need is for researchers to support guidelines 
developers by facilitating evidence-based pragmatic judgements.  Prioritising research that 
addresses the relevant questions is, therefore, a priority. 
For the sake of brevity and focus, we have not discussed a number of important matters related to 
the development of consumption thresholds.  These include the role of drinking patterns and 
contexts, public misunderstanding of units or standard drinks, the focus on gender over other 
sociodemographic characteristics, the possibility of setting multiple consumption thresholds to 
indicate that risks increase gradually and the use of non-epidemiological evidence on the health 
consequences of alcohol (e.g. clinical trials or mechanistic studies).  These omissions are not tacit 
approvals of the status quo.  On the contrary, we encourage debate on each of these points as, in 
different ways, they are likely to shape the effectiveness of drinking guidelines.  Although we do not 
speak directly to those debates, the need to balance evidence, judgement and pragmatism is likely 
to be equally as relevant in those discussions as it is in the present debate.  
Conclusions 
The development of best practice for setting consumption thresholds within drinking guidelines 
remains a work in progress.  Challenges remain relating to the analysis of epidemiological data, the 
application of expert judgement and the pragmatic consideration of how guidelines may function 
after they are set.  Our eight recommendations can help guideline developers, practitioners, 
researchers and policy-makers internationally to produce drinking guidelines that are 
epidemiologically justified, transparently developed, perceived as legitimate by the public, and 
effective when promoted.  
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 Figure 1a: The Canadian approach to setting drinking guidelines as used in our report to the UK 
Guideline Development Group [5] 
 
Figure 1b: The Australian approach to setting drinking guidelines as used in our report to the UK 
Guideline Development Group [5] 
Note: The y-axis in Figure 1b describes the estimated percentage of deaths in the modelled year which would 
be attributable to alcohol if everyone consumed at the level on the x-axis.  The putative protective effect of 
moderate drinking introduces a complication as this curve must either: (a) have negative absolute risks or (b) 
ƵƐĞƚŚĞŶĂĚŝƌŽĨƚŚĞĐƵƌǀĞĂƐƚŚĞǌĞƌŽĂďƐŽůƵƚĞƌŝƐŬƉŽŝŶƚĂŶĚĂƐƐŝŐŶĂƌŝƐŬŽĨ ?ĂůĐŽŚŽů-ĂƚƚƌŝďƵƚĂďůĞ ?ĚĞĂƚŚƚŽ
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abstainers. We present the first option as our analyses for the UK Guideline Development Group required us to 
compare risk curves for different population groups and different drinking patterns within those groups.  This 
comparison would have been impractical if the zero absolute risk point (i.e. the x-axis) were set at the nadir as 
each of the curves has a different nadir.  
 
 
 
 
 
Figure 2: Implied female and male UK guideline thresholds under the Australian approach in the 
hŶŝǀĞƌƐŝƚǇŽĨ^ŚĞĨĨŝĞůĚ ?ƐďĂƐĞĐĂƐĞŵŽĚĞůĂŶĚŝŶƐĞŶƐŝƚŝǀŝƚǇĂŶĂůǇƐĞƐ 
Note: SA=Sensitivity Analysis.  Figures assume that drinkers spread their consumption evenly across four days.  
For the Canadian approach, other consumption patterns and full details of sensitivity analyses, please see the 
modelling report [5].  Note that some results imply a higher guideline for females than males.  This counter-
intuitive finding is due to males facing greater risks of acute harm and, again, is discussed in more detail in the 
modelling report.  
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 Figure 3: Visual representation of the impact and importance of epidemiological judgements taken in 
a hypothetical male guideline development process.  
Note: SA=Sensitivity Analysis  
 Table 1: Recommendations and suggested actions to improve the development of drinking 
guidelines 
Recommendation Suggested actions 
Developing the use of epidemiological evidence when setting consumption thresholds 
1. Appropriately reflect the relationship 
between estimates of population-level and 
individual-level risks. 
a. Make transparent how this has been 
conceptualised within the analytical framework 
(see Recommendation 4). 
b. Consider developing population-level health 
promotion messages.  
2. Develop understanding of the acceptability 
of alcohol-related risks. 
a. Use survey research to understand the 
position of different alcohol-related outcomes 
on dimensions of risk acceptability [42]. 
b. Use discrete choice experiments to identify 
risk acceptability thresholds for alcohol-related 
outcomes and test how revealing the 
associated consumption levels and patterns 
affects these. 
c. Use qualitative focus groups and/or 
interviews to understand how risk acceptability 
informs drinking practices. 
3. Ensure appropriate uncertainty analyses a. Request that epidemiological modellers 
undertake sensitivity analyses on major areas 
of uncertainty where feasible. 
b. Draw on previous uncertainty analyses in this 
area. 
c. Where uncertainty is large and important, 
give this appropriate prominence within 
decision-making. 
Improving the objectivity and transparency of judgements on epidemiological evidence 
4. Ensure judgements on the evidence are clear, 
consistent and coherent. 
a. Develop at an early stage an analytical 
framework to be used across the guideline 
development process, potentially detailing the 
questions, evidence, metrics, procedures and 
considerations in play across all judgements.  
b. Publish and consult upon this framework 
prior to key decision-making. 
5. Make judgements transparent and 
accessible. 
b. Use numerical techniques such as multi-
criteria decision-making or visual techniques 
(e.g. Figure 3) to communicate the importance 
and impact of judgements.  
Making pragmatic considerations meaningful and visible 
6. Give attention to purposes of drinking 
guidelines beyond communicating risk 
information.  
a. Assess the credibility and acceptability of 
alternative guidelines to relevant stakeholders 
and examine the factors which affect this. 
b. Explore how the public accommodate 
guidelines into lay understandings of risks and 
benefits as well as existing health practices. 
c. Examine how stakeholders in multiple sectors 
translate and communicate guidelines to the 
public. 
d. Evaluate and experiment with guidelines and 
associated messages to assess their 
effectiveness across their full range of 
purposes.  
7. Make strategic and positive judgements 
which allow guidelines to function effectively.  
a. Draw on research evidence (see 
Recommendation 6) to select guidelines which 
balance epidemiological concerns with the 
concerns of communicators and others who 
must make the guidelines work in practice.  
8. Make judgements on these wider 
considerations transparent and accessible. 
a. Adapt the methods outlined in 
Recommendation 5 (e.g. Figure 6).  
 
 
